A secondary CD34+ acute lymphoblastic leukemia unmasked and mobilized by G‐CSF in an autologous stem cell donor with testicular cancer

Abstract

AbstractBackgroundLate complications of chemotherapy include treatment‐related secondary leukemias. We describe an unusual case of a new treatment‐related acute lymphoblastic leukemia (t‐ALL) that was unmasked and mobilized by G‐CSF during autologous hematopoietic progenitor cell collection (HPCC) in a young man with testicular cancer.MethodsElectronic chart review of the patient medical history and pertinent laboratory findings. Patient CD34 and blast results were compared to 4249 autologous and 437 allogeneic HPCC performed between 2004 and 2022. In autologous donors, the %blast and %CD34 were compared by linear regression and paired t‐test using commercial software.ResultsThe patient was a 21‐year‐old male with relapsed testicular cancer referred for G‐CSF cytokine‐only mobilization and autologous HPCC. His pre‐mobilization WBC count and differential were normal. On the day of HPCC, his WBC = 37.9 K/mcL with 12% blasts and 9.75% circulating CD34+ cells. The patient was admitted 9 days after HPCC with a normal WBC count and 15% blasts. He was diagnosed with a pro‐B t‐ALL bearing an t(4:11)(q21:q23) translocation and KMT2A‐AF4 rearrangement. Upon review, this patient had the highest %CD34 among 4686 HPCC and was the only donor with %CD34 > 1% after a cytokine‐only mobilization.ConclusionWe report a case of t‐ALL that mimicked CD34+ HPC and was mobilized by high‐dose G‐CSF. Up to 70% of secondary leukemias bear 11q23/KMT2A rearrangements, which occur at the multipotent stem cell stage and can result in myeloid and lymphoid leukemias. Donors who have received past chemotherapy, especially with topoisomerase II inhibitors, are at increased risk for 11q23/KMT2A leukemias.